机译:体外体外活性和时间杀死Sitafloxacin对全球抗菌抗菌和多药抗性奈良奈瑟氏淋病淋病奈瑟氏淋病术分离株
WHO Collaborating Centre for Gonorrhoea and other STIs?rebro University?rebro Sweden;
WHO Collaborating Centre for Gonorrhoea and other STIs?rebro University?rebro Sweden;
WHO Collaborating Centre for Gonorrhoea and other STIs?rebro University?rebro Sweden;
Department of UrologyUniversity of Occupational and Environmental HealthKitakyushu Japan;
WHO Collaborating Centre for Gonorrhoea and other STIs?rebro University?rebro Sweden;
Department of Dermatovenerology?rebro University Hospital?rebro Sweden;
Department of Microbiology and Infection Control Sexually Transmitted Infections Research and;
Department of Bacteriology INational Institute of Infectious DiseasesTokyo Japan;
WHO Collaborating Centre for Gonorrhoea and other STIs?rebro University?rebro Sweden;
Gonorrhoea; fluoroquinolone; in vitro potency; time‐kill curve analysis; bactericidal; quinolone resistance‐determining region; gyrA;
机译:体外体外活性和时间杀死Sitafloxacin对全球抗菌抗菌和多药抗性奈良奈瑟氏淋病淋病奈瑟氏淋病术分离株
机译:在多药抗性临床Neisseria淋病术中酮酮霉素的体外活性,以及国际参考菌株
机译:新型螺旋吡嘧啶三酮AZD0914(一种DNA促旋酶抑制剂)对耐多药性淋病奈瑟氏球菌的分离物具有很高的体外活性,为口服治疗淋病提供了一种新的有效选择
机译:淋病奈瑟氏球菌的光灭活:对抗耐药性淋球菌感染的范式改变方法
机译:淋病奈瑟氏球菌在体外和人类感染过程中的全球RNA分析。
机译:时间杀伤曲线分析和药效学建模用于体外评估淋病奈瑟菌的抗菌药物
机译:时间杀伤曲线分析和药效学建模,用于体外评估淋病奈瑟菌的抗菌药物